In recent developments, Rezolute, a renowned biopharmaceutical company, has achieved significant milestones in their research of two critical medical conditions - Diabetic Macular Edema (DME) and Congenital Hyperinsulinism. The company has reported positive topline results from a Phase 2 proof of concept study of RZ402 in patients with DME, along with good safety profile and a reduction in central subfield thickness (CST). Additionally, Rezolute has initiated a Phase 3 clinical study for RZ358 in Congenital Hyperinsulinism with enrollment completion expected by the end of 2024 and topline results anticipated in mid-year 2025. Furthermore, the company has completed enrollment of its Phase 2 study in DME and p...

Visionary Progress: Rezolute's Revolutionary Study Nears Completion, Paving the Way for Groundbreaking Diabetic Macular Edema Treatments

In a significant milestone for medical research, Rezolute, a prominent biopharmaceutical company, has recently achieved the completion of patient enrollment for its Phase 2 study on Diabetic Macular Edema (DME). This crucial trial aims to evaluate the safety and efficacy of a potential breakthrough treatment, bringing hope to millions of individuals worldwide suffering from diabetic-related vision complications. As Rezolute prepares to reveal its topline data in the mid-second quarter of 2024, the anticipation for potential medical advancements in the field of ophthalmology intensifies.
Background on Diabetic Macular Edema
Diabetic Macular Edema is a serious eye condition that affects peopl...

RZLT's Stock Performance relative to it's Customers

RZLT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Rezolute Inc	434.33	0.00	-77.59	42
SUBTOTAL	0.00	0.00	0.00	-

Sources: Rezolute Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Rezolute Inc’s corporate clients.
For your research, we’ve provided 9 tables on Rezolute Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.